← Leaderboards
Tien L Huang
Xavier University Of Louisiana
$1,093,958
Attributed
$1,093,958
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $189.1K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$1,093,958 · 3
By mechanism
S06$896,865 · 1
R03$139,950 · 1
R24$57,143 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Pentamidine”
- Stephen M Beverley · Washington University$3,320,075
- Scott M Landfear · Oregon Health And Science University$3,182,598
- James M Robins · Harvard University (Sch Of Public Hlth)$2,091,116
- John A Berglund · University Of Oregon$1,713,768
- David M. Dooley · Montana State University (Bozeman)$1,600,214
- Marilyn Parsons · Seattle Biomedical Research Institute$1,487,764
Research focus
PentamidineDrug Design /Synthesis /ProductionPneumocystis PneumoniaDrug Screening /EvaluationAnalogConformationChemical Structure FunctionPneumocystis CariniiAntiprotozoal AgentsNuclear Magnetic Resonance SpectroscopyNeuroprotectantsLaboratory MouseOpportunistic InfectionsNmda ReceptorsLaboratory RatAidsNeuropharmacologyAntifungal AgentsMedical ComplicationMicroorganism CultureMicroorganism Disease ChemotherapyInhibitor /AntagonistLeishmania DonovaniDrug Interactions
Grant awards (12)
Novel Pentamidine Congeners as Anti-opportunistic and Anti-parasitic Agents$189,054
S06 · FY2007 · GM · contact PI
Novel Pentamidine Congeners as Anti-opportunistic and Anti-parasitic Agents$113,382
S06 · FY2006 · GM · contact PI
Novel Pentamidine Congeners as Anti-opportunistic and Anti-parasitic Agents$110,684
S06 · FY2005 · GM
Novel Pentamidine Congeners as Anti-opportunistic and Anti-parasitic Agents$109,565
S06 · FY2004 · GM
NEW AGENTS FOR PNEUMOCYSTIS CARINII PNEUMONIA$148,636
S06 · FY2002 · GM
NEW AGENTS FOR PNEUMOCYSTIS CARINII PNEUMONIA$148,636
S06 · FY2001 · GM
NOVEL ANTI-PCP AGENTS WITH NEUROPROTECTIVE PROPERTIES$69,975
R03 · FY2001 · DA
NEW AGENTS FOR PNEUMOCYSTIS CARINII PNEUMONIA$38,454
S06 · FY2001 · GM
ANTI-PCP AGENTS FOR AIDS AND DRUG ABUSE$0
R24 · FY2001 · DA
NOVEL ANTI-PCP AGENTS WITH NEUROPROTECTIVE PROPERTIES$69,975
R03 · FY2000 · DA
ANTI-PCP AGENTS FOR AIDS AND DRUG ABUSE$57,143
R24 · FY2000 · DA
NEW AGENTS FOR PNEUMOCYSTIS CARINII PNEUMONIA$38,454
S06 · FY2000 · GM